Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
06/2010
06/08/2010CA2266342C Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
06/08/2010CA2210956C Method for preparing a recombinant adenovirus genome
06/03/2010WO2010062837A2 Multivalent, drying resistant, evolution-based vaccines
06/03/2010WO2010062757A1 Improved methods for isolating enveloped virus-based vlps free of infectious agents
06/03/2010WO2010061000A1 Novel porcine circovirus type 2b isolate and uses thereof
06/03/2010WO2010060719A1 Method for the production of adenoviral vectors
06/03/2010WO2010060200A1 Bacteriophage compositions for treatment of bacterial infections
06/03/2010WO2009151697A9 Compositions and processes relating to human bocavirus
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137437 Composition for Inactivating an Enveloped Virus
06/03/2010US20100136692 Plasmids and phages for homologous recombination and methods of use
06/03/2010US20100136660 Methods for producing members of specific binding pairs
06/03/2010US20100136659 Infectious cDNA Clone of North American Porcine Reproductive and Respiratory Syndrome (PPRS) Virus and Uses Thereof
06/03/2010US20100136658 Generation of oncolytic adenoviruses and uses thereof
06/03/2010US20100136657 Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products
06/03/2010US20100136597 Method for modularting activity of t lymphocytes
06/03/2010US20100136522 Endogenous retroviruses up-regulated in prostate cancer
06/03/2010US20100136518 Antibodies useful for therapy and diagnosis of cancer
06/03/2010US20100136514 Infectious clone of human parvovirus b19 and methods
06/03/2010US20100136056 Novel insertion sites in pox vectors
06/03/2010US20100136055 Chimeric pestiviruses
06/03/2010US20100136052 Replication deficient influenza virus for the expression of heterologous sequences
06/03/2010US20100136051 N Protein Muants of Porcine Reproductive and Respiratory Syndrome Virus
06/03/2010US20100136047 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use
06/03/2010US20100136016 Heat shock proteins from mycobacterium leprae and uses thereof
06/03/2010US20100135962 Novel Bacteriophage and Antibacterial Composition Comprising the Same
06/03/2010CA2744909A1 Bacteriophage compositions for treatment of bacterial infections
06/03/2010CA2742474A1 Method for the production of adenoviral vectors
06/03/2010CA2742295A1 Improved methods for isolating enveloped virus-based vlps free of infectious agents
06/02/2010EP2192175A1 Animal-free cell culture method
06/02/2010EP2192173A1 Immortalized avian cell lines for virus production
06/02/2010EP2192131A1 Immunoglobulins devoid of light chains
06/02/2010EP2191845A1 Immunology significant herpes simplex virus antigens and methods for using same
06/02/2010EP1768697B1 Recombinant rabies virus compositions
06/02/2010EP1697521B1 Multi plasmid system for the production of influenza virus
06/02/2010EP1265480B1 Chimeric animal model susceptible to human hepatitis c virus infection
06/02/2010CN1840656B Methods to culture circovirus
06/02/2010CN101717754A Enterovirus type 71 and use thereof
06/01/2010US7727757 For invoking an immune response, delaying the onset of AIDS in an animal exposed to infectious HIV
06/01/2010US7727543 Biodegradable carrier and method for preparation thereof
06/01/2010US7727534 Gentically engineered viral particles for use in targeted tumor destruction; Antitumor agents
06/01/2010CA2424700C Genetic immunisation against cervical carcinoma
06/01/2010CA2358915C Modified hiv env polypeptides
06/01/2010CA2352231C Stable, attenuated rabies virus mutants and live vaccines thereof
06/01/2010CA2332627C Porcine circovirus and parvovirus vaccine
06/01/2010CA2291851C Stabilized antithrombin iii preparation
05/2010
05/27/2010WO2010060114A1 Chimeric pestivirus with insertion in 3' nontranslated region (3' ntr) with stable replication and rnase resistance
05/27/2010WO2010060054A1 Bacteriophage derived methods to control lactic acid bacterial growth
05/27/2010WO2010059232A1 Arginine inactivation of viruses
05/27/2010US20100130513 Benzimidazoles and analogs thereof as antivirals
05/27/2010US20100130381 Novel hiv-1 reverse transcriptase codon deletion and its use in the management and treatment of hiv infections
05/27/2010US20100129893 Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin
05/27/2010US20100129889 Affinity separation methods and systems
05/27/2010US20100129405 Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
05/27/2010US20100129401 Functional Influenza Virus Like Particles (VLPs)
05/27/2010US20100129399 Linear expression constructs for production of influenza virus particles
05/27/2010US20100129395 Hapten-carrier conjugates and uses thereof
05/27/2010US20100129326 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
05/27/2010US20100129325 Seneca valley virus based compositions and methods for treating disease
05/27/2010CA2743012A1 Rsv f vlps and methods of manufacture and use thereof
05/27/2010CA2742817A1 Arginine inactivation of viruses
05/26/2010EP1956087B1 High production system for infectious hepatitis c virus particle
05/26/2010CN1961961B A pharmaceutical formulation and preparation process thereof
05/26/2010CN1833027B Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
05/26/2010CN1829796B Novel full-length genomic RNA of Japanese encephalitis virus, infectious JEV cDNA therefrom, and use thereof
05/26/2010CN1756837B Animal-free cell culture method
05/26/2010CN1746298B Artificial recombinant H7 subinfluenza virus and use thereof
05/26/2010CN1668637B Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
05/26/2010CN1578678B Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
05/26/2010CN101715487A influenza b viruses having alterations in the hemaglutinin polypeptide
05/26/2010CN101712965A Japanese encephalitis virus JEV replicon vector and application thereof
05/26/2010CN101712949A Gm-negative ehv-mutants without heterologous elements
05/26/2010CN101711864A gm-negative ehv-mutants without heterologous elements
05/26/2010CN101065480B Animal protein-free media for cultivation of cells
05/25/2010US7723270 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering
05/25/2010US7723094 Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy
05/25/2010CA2321964C Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus
05/25/2010CA2199715C Novel implant and novel vector for the treatment of acquired diseases
05/20/2010WO2010056966A2 Novel hiv-2 isolate
05/20/2010WO2010056093A1 Method for isolating the dna of the avian infectious laryngotracheitis virus for pcr analysis
05/20/2010WO2009073103A3 Simian subfamily b adenoviruses sadv-28,27,-29,-32,-33, and -35 and uses thereof
05/20/2010US20100124546 Adenovirus With Mutations in the Endoplasmic Reticulum Retention Domain of the E3-19K Protein and Their Use in Cancer Treatment
05/20/2010CA2743853A1 Novel hiv-2 isolate
05/19/2010EP2186893A1 Production and use of epitope-tagged hepatitis c virus particle
05/19/2010EP2186885A1 Animal-free cell culture method
05/19/2010EP2185591A1 Production method
05/19/2010CN101711278A T4 bacteriophage bound to a substrate
05/19/2010CN101709292A Recombinant adenovirus, and preparation method and application thereof
05/19/2010CN101708332A Rabbit triple inactivated vaccine, preparation method and application thereof
05/19/2010CN101220350B Separated Listeria monocytogenes phage and uses thereof
05/19/2010CN101003794B Method for constructing recombined adenovirus in PEX outer secretion type of human and application
05/18/2010US7718424 AAV4 vector and uses thereof
05/18/2010US7718401 Expression of HIV polypeptides and production of virus-like particles
05/18/2010US7718180 Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
05/18/2010CA2557882C Defective packaging non-oncoviral vectors based on mpmv and hiv
05/14/2010WO2010053883A1 Live, attentuated respiratory syncytial virus
05/14/2010WO2010052214A2 Novel method
05/14/2010CA2742086A1 Live, attenuated respiratory syncytial virus
05/14/2010CA2741961A1 Novel method
05/13/2010US20100120122 Targeted gene delivery for dendritic cell vaccination
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 267